Abstract:The high incidence of complex diseases has become a worldwide threat to human health. Multiple targets and pathways are perturbed during the pathological process of complex diseases. Systematic investigation of complex relationship between drugs and diseases is necessary for new association discovery and drug repurposing. For this purpose, three causal networks were constructed herein for cardiovascular diseases, diabetes mellitus, and neoplasms, respectively. A causal inference-probabilistic matrix factorization (CI-PMF) approach was proposed to predict and classify drug-disease associations, and further used for drug-repositioning predictions. First, multilevel systematic relations between drugs and diseases were integrated from heterogeneous databases to construct causal networks connecting drug-target-pathway-gene-disease. Then, the association scores between drugs and diseases were assessed by evaluating a drug's effects on multiple targets and pathways. Furthermore, PMF models were learned based on known interactions, and associations were then classified into three types by trained models. Finally, therapeutic associations were predicted based upon the ranking of association scores and predicted association types. In terms of drug-disease association prediction, modified causal inference included in CI-PMF outperformed existing causal inference with a higher AUC (area under receiver operating characteristic curve) score and greater precision. Moreover, CI-PMF performed better than single modified causal inference in predicting therapeutic drug-disease associations. In the top 30% of predicted associations, 58.6% (136/232), 50.8% (31/61), and 39.8% (140/352) hit known therapeutic associations, while precisions obtained by the latter were only 10.2% (231/2264), 8.8% (36/411), and 9.7% (189/1948). Clinical verifications were further conducted for the top 100 newly predicted therapeutic associations. As a result, 21, 12, and 32 associations have been studied and many treatment effects of drugs on diseases were investigated for cardiovascular diseases, diabetes mellitus, and neoplasms, respectively. Related chains in causal networks were extracted for these 65 clinical-verified associations, and we further illustrated the therapeutic role of etodolac in breast cancer by inferred chains. Overall, CI-PMF is a useful approach for associating drugs with complex diseases and provides potential values for drug repositioning.

A Method for Improving the Reliability of Causal Inference from Large-Scale Data in Biomedicine.

Data Integration in Causal Inference

Causal inference in drug discovery and development

A Survey on Causal Inference

Learning interpretable causal networks from very large datasets, application to 400,000 medical records of breast cancer patients

Drug-Disease Association and Drug-Repositioning Predictions in Complex Diseases Using Causal Inference-Probabilistic Matrix Factorization

Valid Inference After Causal Discovery

Causal Inference and Related Statistical Methods

When deep learning meets causal inference: a computational framework for drug repurposing from real-world data

Practical Approaches to Causal Relationship Exploration

Predicting Drug-Target Interactions by Measuring Confidence with Consistent Causal Neighborhood Interventions

From Observational Studies to Causal Rule Mining

Statistical Approaches for Causal Inference

Effective and Scalable Causal Partitioning Based on Low-Order Conditional Independent Tests.

Causal Inference in Observational Data

CausalBench: A Large-scale Benchmark for Network Inference from Single-cell Perturbation Data

Causal Gene Identification Using Non-linear Regression-based Independence Tests

Collaborative causal inference with a distributed data-sharing management

Direct causal variable discovery leveraging the invariance principle: application in biomedical studies

Methods and Applications of Causal Reasoning in Medical Field

A flexible approach for causal inference with multiple treatments and clustered survival outcomes